Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Gene record

TMEM63A

transmembrane protein 63A

translation score 0.51, read 2026-10-25; 2 sealed predictions, 0 held; 3 receipts.

Six readers

readerfoundscore
genetics
Open Targets
no genetic evidence; overall 0.01 from other evidence0.00
cell type
Human Protein Atlas
cell type enhanced, including oligodendrocytes; strongest in tuft cells0.75
chemistry
Open Targets
a small-molecule pocket0.60
trials
ClinicalTrials.gov
no Parkinson's trials on record: an open field1.00
literature
PubMed
1 Parkinson's papers of 540.91
pathways
Reactome
1 pathway; mostly other0.30

No case: the score is under the bar. Receipt 9442

Sealed predictions

  1. TMEM63A in dopamine neurons, braak-0.31 (p 0.414) → -0.14 (p 0.723)receipt 9450
  2. TMEM63A in oligodendrocytes, braak+0.10 (p 0.802) → -0.60 (p 0.086)receipt 9449

Swarm cases

receipt 9450: TMEM63A in dopamine neurons, braak

power
full sample -0.16 (p 0.515, n 18), 95% CI -0.59 to +0.33. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.22 (p 0.389, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.21 (p 0.413, n 18). could be the mix.
skeptic
leave-one-out range -0.33 to -0.08, sign flips 0; without severely affected donors -0.16 (p 0.515, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for TMEM63A in dopamine neurons.

case closed: nothing better to follow up.

receipt 9449: TMEM63A in oligodendrocytes, braak

power
full sample -0.24 (p 0.346, n 18), 95% CI -0.63 to +0.26. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.30 (p 0.221, n 18). does not hold up.
composition
oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.38 (p 0.125, n 18). could be the mix.
skeptic
leave-one-out range -0.41 to -0.13, sign flips 0; without severely affected donors -0.24 (p 0.346, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for TMEM63A in oligodendrocytes.

case closed: nothing better to follow up.

Receipts

loading the receipts